CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Brett Monia

Chief Executive Officer, Ionis Pharmaceuticals, Inc.

Search every verified Brett Monia interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Brett Monia, Ph.D., CEO of Ionis Pharmaceuticals, discussed the company's evolution and strategy in a recent podcast interview. He described Ionis's shift from a partner-first model to a wholly-owned pipeline with its own commercial and manufacturing capabilities, a change he said he initiated after feeling that external partners sometimes deprioritized Ionis's drug programs. Monia, who became CEO in 2020 after serving as a founding scientist, noted that he had no prior commercial experience but felt the business model needed to change to deliver medicines directly to patients. Monia also addressed the company's pipeline, mentioning expectations for three drug approvals in the current year and continued late-stage and mid-stage readouts through 2027 and beyond. In a separate quote, he expressed disappointment with negative attitudes toward RNA-based vaccines, attributing such criticism to broader vaccine skepticism rather than the RNA technology itself, which he noted was instrumental in rapidly developing COVID-19 vaccines.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →